| 摘要 |
The invention provides proteolytic enzyme-containing compositions which, on administration, optimize the in vivo viscosity of the mucuses and which are characterized by bringing the magnitude of the in vitro viscosity to a value generally between those values obtained when mucus is subjected to identical treatments with trypsin and chymotrypsin; they are also characterized by being insensitive to trypsin inhibitors.
|
